1084 related articles for article (PubMed ID: 17919620)
1. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
[TBL] [Abstract][Full Text] [Related]
2. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
4. Does Perfadex affect outcomes in clinical lung transplantation?
Nath DS; Walter AR; Johnson AC; Radosevich DM; Prekker ME; Herrington CS; Dahlberg PS; Kelly RF
J Heart Lung Transplant; 2005 Dec; 24(12):2243-8. PubMed ID: 16364877
[TBL] [Abstract][Full Text] [Related]
5. Outcome of lung transplanted patients with primary graft dysfunction.
Burton CM; Iversen M; Milman N; Zemtsovski M; Carlsen J; Steinbrüchel D; Mortensen J; Andersen CB
Eur J Cardiothorac Surg; 2007 Jan; 31(1):75-82. PubMed ID: 17134909
[TBL] [Abstract][Full Text] [Related]
6. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
7. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases.
Aigner C; Jaksch P; Taghavi S; Lang G; Reza-Hoda MA; Wisser W; Klepetko W
J Heart Lung Transplant; 2008 Jan; 27(1):60-5. PubMed ID: 18187088
[TBL] [Abstract][Full Text] [Related]
9. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for primary graft dysfunction after lung transplantation.
Whitson BA; Nath DS; Johnson AC; Walker AR; Prekker ME; Radosevich DM; Herrington CS; Dahlberg PS
J Thorac Cardiovasc Surg; 2006 Jan; 131(1):73-80. PubMed ID: 16399297
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry.
Fischer S; Bohn D; Rycus P; Pierre AF; de Perrot M; Waddell TK; Keshavjee S
J Heart Lung Transplant; 2007 May; 26(5):472-7. PubMed ID: 17449416
[TBL] [Abstract][Full Text] [Related]
14. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
15. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
[TBL] [Abstract][Full Text] [Related]
16. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
17. Long-term pulmonary function after living-donor lobar lung transplantation in adults.
Bowdish ME; Pessotto R; Barbers RG; Schenkel FA; Starnes VA; Barr ML
Ann Thorac Surg; 2005 Feb; 79(2):418-25. PubMed ID: 15680807
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
19. Status of lung transplant recipients surviving beyond five years.
Chaparro C; Scavuzzo M; Winton T; Keshavjee S; Kesten S
J Heart Lung Transplant; 1997 May; 16(5):511-6. PubMed ID: 9171269
[TBL] [Abstract][Full Text] [Related]
20. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
